Literature DB >> 3073386

Drug discovery--today and tomorrow: the role of medicinal chemistry.

K R Freter1.   

Abstract

Novel drugs presently introduced in the market are largely not discovered by rational design or by random screening but, rather, are products of evolution of existing leads (analogue research). It is suggested that this will change in the near future. Progress in a number of scientific disciplines will make it likely that drug design, but also systematic screening, will contribute more and more to novel drug discovery.

Mesh:

Year:  1988        PMID: 3073386     DOI: 10.1023/a:1015924014805

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  3 in total

1.  A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus.

Authors:  R S Chang; V J Lotti; R L Monaghan; J Birnbaum; E O Stapley; M A Goetz; G Albers-Schönberg; A A Patchett; J M Liesch; O D Hensens
Journal:  Science       Date:  1985-10-11       Impact factor: 47.728

2.  Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

Authors:  B E Evans; M G Bock; K E Rittle; R M DiPardo; W L Whitter; D F Veber; P S Anderson; R M Freidinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 3.  Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.